Citius Oncology, Inc.

CTOR·NasdaqCM·Healthcare
Compare
0.5470−0.0030 (−0.55%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market0.5980+0.0510 (+9.32%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.5500
Open0.5564
Day range0.54010.5947
52-week range0.49101.8300
Off day high−8.02%
Off 52-week high−70.11%
Volume79.86K
Avg. volume (3M)126.24K
Market cap57.85M
EPS (TTM)-0.4800
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)3.58
Shares outstanding105.76M
Short interest0.77% of float
Earnings date—
Analyst target4.0000
Profit margin0.00%

Against its peers

Compare in full ›
CTOR GUD.TO 688321.SS I7G.F 300558.SZ CTXR
Market cap 57.85M 1.11B 9.47B 12.79B 20.76B 15.13M
P/E (TTM) — 75.3 133.7 25.1 77.9 —
Forward P/E — 43.5 -107.0 — 29.2 -0.4
Price/book 1.4 1.4 3.7 2.7 3.2 0.2
Dividend yield — — 0.28% 1.05% 0.31% —
1-year change −64.29% +92.81% −31.78% +22.89% −12.57% −58.18%
Today −0.55% +0.36% +2.84% +2.04% +1.62% −3.87%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All CTOR news ›
Defense World·Positive

Analyzing Citius Oncology (CTOR) and Its Rivals

Posted by Defense World Staff on Oct 31st, 2026 Citius Oncology (NASDAQ:CTOR – Get Free Report) is one of 844 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its rivals? We will compare…

From the 4Search news index, newest first.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance